Clinical Trial Update: Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy [Phase 3]

View source ↗

Summary

Phase 3 study assessing tanezumab for cancer pain due to bone metastasis in patients on background opioids has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis
• Cancer Pain

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Bone Metastasis, Cancer Pain | Phase 3 | Status: COMPLETED | Results posted: 2023-01-20